Preferred Label : eptacog beta;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3408648/fr/cevenfacta-eptacog-beta-fviia-hemophilie-congenitale
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
eptacog beta
coagulation factor VIIa
adult
adolescent
hemorrhage
hemorrhage
hemophilia A
evaluation of the transparency committee

---
https://www.ema.europa.eu/en/medicines/human/EPAR/cevenfacta
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
eptacog beta
eptacog beta
recombinant FVIIa
recombinant FVIIa
coagulation factor VIIa
product surveillance, postmarketing
adult
adolescent
blood loss, surgical
blood loss, surgical
injections, intravenous
hemophilia A
Genetic Engineering

---
Nous contacter.
06/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.